We are live on
!
Find out more
SM
Scale Management Portfolio holdings
AUM
$359M
This Fund
S&P 500
This Quarter
Est. Return
+29.98%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$200M
AUM Growth
+$25.1M
(+14%)
Cap. Flow
-$10.8M
Cap. Flow
% of AUM
-5.37%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$9.06M |
| 2 |
RingCentral
RNG
|
+$875K |
| 3 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
+$826K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.88% |
| 2 | Technology | 44.02% |
Similar funds
SIVVM
NFG
RA
AWW
FRGX
GBBWRPM
RCA
MCM
Scale Management's Q1 2015 Portfolio in Review
As of Q1 2015, Scale Management held 6 positions worth $200M, up 14% from $175M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Scale Management withdrew a net $10.8M in Q1 2015, reducing 3 holdings. Its largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $9.06M.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 41% a quarter earlier, followed by Technology.
- Scale Management's biggest Q1 2015 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $9.06M.
- Scale Management's ten largest holdings make up 100% of its $200M portfolio in Q1 2015.
- Scale Management opened 0 new positions and closed 0 in Q1 2015.
- Scale Management's portfolio value rose 14% quarter-over-quarter to $200M.
Based on Scale Management's 13F filing for Q1 2015, filed 2 Jun 2015.